Targeting the cell wall of Mycobacterium tuberculosis: structure and mechanism of L,D-transpeptidase 2
- PMID: 23103390
- PMCID: PMC3573878
- DOI: 10.1016/j.str.2012.09.016
Targeting the cell wall of Mycobacterium tuberculosis: structure and mechanism of L,D-transpeptidase 2
Abstract
With multidrug-resistant cases of tuberculosis increasing globally, better antibiotic drugs and novel drug targets are becoming an urgent need. Traditional β-lactam antibiotics that inhibit D,D-transpeptidases are not effective against mycobacteria, in part because mycobacteria rely mostly on L,D-transpeptidases for biosynthesis and maintenance of their peptidoglycan layer. This reliance plays a major role in drug resistance and persistence of Mycobacterium tuberculosis (Mtb) infections. The crystal structure at 1.7 Å resolution of the Mtb L,D-transpeptidase Ldt(Mt2) containing a bound peptidoglycan fragment, reported here, provides information about catalytic site organization as well as substrate recognition by the enzyme. Based on our structural, kinetic, and calorimetric data, we propose a catalytic mechanism for Ldt(Mt2) in which both acyl-acceptor and acyl-donor substrates reach the catalytic site from the same, rather than different, entrances. Together, this information provides vital insights to facilitate development of drugs targeting this validated yet unexploited enzyme.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Figures
Similar articles
-
Crystal structure of L,D-transpeptidase LdtMt2 in complex with meropenem reveals the mechanism of carbapenem against Mycobacterium tuberculosis.Cell Res. 2013 May;23(5):728-31. doi: 10.1038/cr.2013.53. Epub 2013 Apr 16. Cell Res. 2013. PMID: 23588382 Free PMC article. No abstract available.
-
Structures of free and inhibited forms of the L,D-transpeptidase LdtMt1 from Mycobacterium tuberculosis.Acta Crystallogr D Biol Crystallogr. 2013 Sep;69(Pt 9):1697-706. doi: 10.1107/S0907444913013085. Epub 2013 Aug 15. Acta Crystallogr D Biol Crystallogr. 2013. PMID: 23999293
-
In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems.Antimicrob Agents Chemother. 2013 Dec;57(12):5940-5. doi: 10.1128/AAC.01663-13. Epub 2013 Sep 16. Antimicrob Agents Chemother. 2013. PMID: 24041897 Free PMC article.
-
Structure and Function of L,D- and D,D-Transpeptidase Family Enzymes from Mycobacterium tuberculosis.Curr Med Chem. 2020;27(19):3250-3267. doi: 10.2174/0929867326666181203150231. Curr Med Chem. 2020. PMID: 30501595 Review.
-
Fluorescent probes for investigating peptidoglycan biosynthesis in mycobacteria.Curr Opin Chem Biol. 2020 Aug;57:50-57. doi: 10.1016/j.cbpa.2020.04.006. Epub 2020 Jun 9. Curr Opin Chem Biol. 2020. PMID: 32531742 Review.
Cited by
-
Structural basis for the inhibition of Mycobacterium tuberculosis L,D-transpeptidase by meropenem, a drug effective against extensively drug-resistant strains.Acta Crystallogr D Biol Crystallogr. 2013 Mar;69(Pt 3):420-31. doi: 10.1107/S0907444912048998. Epub 2013 Feb 16. Acta Crystallogr D Biol Crystallogr. 2013. PMID: 23519417 Free PMC article.
-
The l,d-Transpeptidase LdtAb from Acinetobacter baumannii Is Poorly Inhibited by Carbapenems and Has a Unique Structural Architecture.ACS Infect Dis. 2022 Sep 9;8(9):1948-1961. doi: 10.1021/acsinfecdis.2c00321. Epub 2022 Aug 16. ACS Infect Dis. 2022. PMID: 35973205 Free PMC article.
-
Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase LdtMt2 by biapenem and tebipenem.BMC Biochem. 2017 May 25;18(1):8. doi: 10.1186/s12858-017-0082-4. BMC Biochem. 2017. PMID: 28545389 Free PMC article.
-
Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.Antimicrob Agents Chemother. 2017 Sep 22;61(10):e00866-17. doi: 10.1128/AAC.00866-17. Print 2017 Oct. Antimicrob Agents Chemother. 2017. PMID: 28760902 Free PMC article.
-
Structure of Enterococcus faeciuml,d-transpeptidase acylated by ertapenem provides insight into the inactivation mechanism.ACS Chem Biol. 2013;8(6):1140-6. doi: 10.1021/cb4001603. Epub 2013 Apr 12. ACS Chem Biol. 2013. PMID: 23574509 Free PMC article.
References
-
- Amzel LM, Poljak RJ. Three-dimensional structure of immunoglobulins. Annu Rev Biochem. 1979;48:961–997. - PubMed
-
- ATS Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med. 1997;156:S1–25. - PubMed
-
- Barreteau H, Kovac A, Boniface A, Sova M, Gobec S, Blanot D. Cytoplasmic steps of peptidoglycan biosynthesis. FEMS Microbiol Rev. 2008;32:168–207. - PubMed
-
- Bateman A, Bycroft M. The structure of a LysM domain from E. coli membrane-bound lytic murein transglycosylase D (MltD) J Mol Biol. 2000;299:1113–1119. - PubMed
-
- Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Molecular Microbiology. 2002;43:717–731. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
